Skip to main content

Table 3 Mixed model regression: symptom (subscales) T-scores on treatment category

From: Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment

Treatment group

(Reference: no treatment)

T-score, all symptoms

B (95% CI)

T-score, somatic

B (95% CI)

T-score, sleep

B (95% CI)

T-score, neuropsychiatric

B (95% CI)

Peg-IFN + RBV

2.89 (1.03, 4.75)**

2.36 (0.33, 4.38)*

1.85 (−0.21, 3.91)

2.43 (0.48, 4.39)*

Peg-IFN + RBV + TPV

4.06 (2.23, 5.89)***

4.22 (2.54, 5.89)***

0.59 (−1.68, 2.85)

2.88 (0.94, 4.82)**

IFN-free DAA

−2.18 (−3.78, − 0.58)**

−1.763 (−3.22, − 0.31)*

−0.99 (−2.53, − 0.55)

−2.23 (−3.95, − 0.52)*

Constant

49.42 (47.69, 51.15)***

49.29 (47.64, 50.95)***

49.93 (48.35, 51.52)***

49.95 (48.16, 51.75)***

No. of patients

103

103

103

103

ICC

0.62

0.63

0.60

0.59

  1. B Beta coefficient, CI Confidence intervals, Peg-IFN Pegylated interferon, RBV Ribavirin, TPV telaprevir, ICC intraclass correlation coefficient
  2. t statistic p values: * p < 0.05; ** p < 0.01; *** p < 0.001